Haemonetics Corp. (HAE) CFO &amp Vice President of Christopher J Lindop sells 17,832 Shares

CFO &amp Vice President of of Haemonetics Corp. (HAE, Financial) Christopher J Lindop sells 17,832 shares of HAE on 12/13/2010 at an average price of $62.48 a share.

Haemonetics Corp. has a market cap of $1.54 billion; its shares were traded at around $62.25 with a P/E ratio of 20.8 and P/S ratio of 2.4. Haemonetics Corp. had an annual average earning growth of 10.1% over the past 10 years. GuruFocus rated Haemonetics Corp. the business predictability rank of 4.5-star.

HAE is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Pioneer Investments, Jim Simons of Renaissance Technologies LLC, Jean-Marie Eveillard of First Eagle Investment Management, LLC.

Directors and Officers Recent Trades:

  • Sell: VP Finance Susan M Hanlon sold 3,500 shares of HAE stock on 12/06/2010 at the average price of 60.99. Susan M Hanlon owns at least 6,584 shares after this. The price of the stock has increased by 2.07% since.

  • Sell: VP, Corporate Affairs Alicia R Lopez sold 96,656 shares of HAE stock on 12/03/2010 at the average price of 60.91. Alicia R Lopez owns at least 11,117 shares after this. The price of the stock has increased by 2.2% since.

  • Sell: Director Pedro P Granadillo sold 6,000 shares of HAE stock on 11/05/2010 at the average price of 57.72. Pedro P Granadillo owns at least 5,501 shares after this. The price of the stock has increased by 7.85% since.

  • Sell: Director Ronald Merriman sold 7,000 shares of HAE stock on 11/04/2010 at the average price of 58.11. Ronald Merriman owns at least 5,201 shares after this. The price of the stock has increased by 7.12% since.

  • Sell: Chief Marketing Officer Peter M Allen sold 1,866 shares of HAE stock on 09/10/2010 at the average price of 54.83. Peter M Allen owns at least 5,999 shares after this. The price of the stock has increased by 13.53% since.